Receive the best resource for the biotech industry with Bio.News, the only daily newsletter at the intersection of biotech, politics and policy.

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary. “Dr.

How to make the most of partnering at BIO 2026. Plus our explainer on PDUFA. (719 words, 2 minutes, 53 seconds) Experts break down strategies for business development at BIO 2026 Experts explained how ...

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

As monoclonal antibody (mAb) programs approach IND, delays often stem from fragmented development, tech transfer complexity, and limited process efficiency. In this webinar, Thermo Fisher Scientific ...

At the 2026 BIO International Convention, we come together Driven by Purpose to forge meaningful connections and advance innovations that improve lives. Successful partnering starts with a clear ...

BIO last week launched the “Fight of Our Lives,” a campaign sharing stories of the people who tackle health challenges every day and underscoring the urgency of their fight. Why it matters: Over the ...

Americans want healthcare reforms that directly lower out-of-pocket costs while protecting the U.S. biotech industry and the numerous cutting-edge medicines, millions of jobs, and trillions in ...